Drugs / senfrol
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04968613 Comparator | Jan 2018 → Dec 2021 | Parkinson disease, cognitive disorder | Peking University Third Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | senfrol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04968613 ↗ |
| Action | Activate | “senfrol (D2 receptor agonist)” NCT04968613 ↗ |